These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 18922916)
1. Cell motility in chronic lymphocytic leukemia: defective Rap1 and alphaLbeta2 activation by chemokine. Till KJ; Harris RJ; Linford A; Spiller DG; Zuzel M; Cawley JC Cancer Res; 2008 Oct; 68(20):8429-36. PubMed ID: 18922916 [TBL] [Abstract][Full Text] [Related]
2. Chemokine unresponsiveness of chronic lymphocytic leukemia cells results from impaired endosomal recycling of Rap1 and is associated with a distinctive type of immunological anergy. Pye DS; Rubio I; Pusch R; Lin K; Pettitt AR; Till KJ J Immunol; 2013 Aug; 191(3):1496-504. PubMed ID: 23804711 [TBL] [Abstract][Full Text] [Related]
3. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow. Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181 [TBL] [Abstract][Full Text] [Related]
4. Chemokines stimulate human T lymphocyte transendothelial migration to utilize VLA-4 in addition to LFA-1. Ding Z; Xiong K; Issekutz TB J Leukoc Biol; 2001 Mar; 69(3):458-66. PubMed ID: 11261794 [TBL] [Abstract][Full Text] [Related]
5. Regulation of lymphocyte adhesion and migration by the small GTPase Rap1 and its effector molecule, RAPL. Kinashi T; Katagiri K Immunol Lett; 2004 Apr; 93(1):1-5. PubMed ID: 15134891 [TBL] [Abstract][Full Text] [Related]
6. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. Shimonaka M; Katagiri K; Nakayama T; Fujita N; Tsuruo T; Yoshie O; Kinashi T J Cell Biol; 2003 Apr; 161(2):417-27. PubMed ID: 12707305 [TBL] [Abstract][Full Text] [Related]
7. Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces. Woolf E; Grigorova I; Sagiv A; Grabovsky V; Feigelson SW; Shulman Z; Hartmann T; Sixt M; Cyster JG; Alon R Nat Immunol; 2007 Oct; 8(10):1076-85. PubMed ID: 17721537 [TBL] [Abstract][Full Text] [Related]
8. CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium. Till KJ; Spiller DG; Harris RJ; Chen H; Zuzel M; Cawley JC Blood; 2005 Jun; 105(12):4813-9. PubMed ID: 15731179 [TBL] [Abstract][Full Text] [Related]
9. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907 [TBL] [Abstract][Full Text] [Related]
10. The Par polarity complex regulates Rap1- and chemokine-induced T cell polarization. Gérard A; Mertens AE; van der Kammen RA; Collard JG J Cell Biol; 2007 Mar; 176(6):863-75. PubMed ID: 17353362 [TBL] [Abstract][Full Text] [Related]
11. Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Katagiri K; Ohnishi N; Kabashima K; Iyoda T; Takeda N; Shinkai Y; Inaba K; Kinashi T Nat Immunol; 2004 Oct; 5(10):1045-51. PubMed ID: 15361866 [TBL] [Abstract][Full Text] [Related]
12. Intracellular signaling required for CCL25-stimulated T cell adhesion mediated by the integrin alpha4beta1. Parmo-Cabañas M; García-Bernal D; García-Verdugo R; Kremer L; Márquez G; Teixidó J J Leukoc Biol; 2007 Aug; 82(2):380-91. PubMed ID: 17510295 [TBL] [Abstract][Full Text] [Related]
13. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia. Montresor A; Toffali L; Mirenda M; Rigo A; Vinante F; Laudanna C Oncotarget; 2015 Oct; 6(33):34245-57. PubMed ID: 26413812 [TBL] [Abstract][Full Text] [Related]
14. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. Ghia P; Chiorazzi N; Stamatopoulos K J Intern Med; 2008 Dec; 264(6):549-62. PubMed ID: 19017179 [TBL] [Abstract][Full Text] [Related]
15. Src homology 2-domain containing leukocyte-specific phosphoprotein of 76 kDa is mandatory for TCR-mediated inside-out signaling, but dispensable for CXCR4-mediated LFA-1 activation, adhesion, and migration of T cells. Horn J; Wang X; Reichardt P; Stradal TE; Warnecke N; Simeoni L; Gunzer M; Yablonski D; Schraven B; Kliche S J Immunol; 2009 Nov; 183(9):5756-67. PubMed ID: 19812192 [TBL] [Abstract][Full Text] [Related]
16. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855 [TBL] [Abstract][Full Text] [Related]
17. Chapter 14. Real-time in vitro assays for studying the role of chemokines in lymphocyte transendothelial migration under physiologic flow conditions. Shulman Z; Alon R Methods Enzymol; 2009; 461():311-32. PubMed ID: 19480925 [TBL] [Abstract][Full Text] [Related]
18. RGS10 restricts upregulation by chemokines of T cell adhesion mediated by α4β1 and αLβ2 integrins. García-Bernal D; Dios-Esponera A; Sotillo-Mallo E; García-Verdugo R; Arellano-Sánchez N; Teixidó J J Immunol; 2011 Aug; 187(3):1264-72. PubMed ID: 21705617 [TBL] [Abstract][Full Text] [Related]
19. The role of chemokines in B cell chronic lymphocytic leukaemia: pathophysiological aspects and clinical impact. Schröttner P; Leick M; Burger M Ann Hematol; 2010 May; 89(5):437-46. PubMed ID: 20020127 [TBL] [Abstract][Full Text] [Related]
20. Guanine nucleotide-binding proteins of the G12 family shape immune functions by controlling CD4+ T cell adhesiveness and motility. Herroeder S; Reichardt P; Sassmann A; Zimmermann B; Jaeneke D; Hoeckner J; Hollmann MW; Fischer KD; Vogt S; Grosse R; Hogg N; Gunzer M; Offermanns S; Wettschureck N Immunity; 2009 May; 30(5):708-20. PubMed ID: 19409815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]